AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)

Optimizing the Use of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Patient Management (ID 439)

Lecture Time
12:30 - 12:30
Speakers
  • All Speakers (na, Swaziland)
Authors
  • All Speakers (na, Swaziland)
Session Name
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30